chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately after IM administration of vaccine, patient lost consciousness and seemed to be seizing  while seating in his chair. Patient regained consciousness within the same minute. Pharmacy manager was immediately called over. We gave the patient water and had him wait for observation for 30 minutes post vaccine administration. Patient mentioned that he had similar syncope episode after receiving HPV vaccine.
pt recv vax 9JUN95 & on 10JUL95 pt exp neck pain, back pain & fever;18JUL95 pt was dizzy & unable to walk & was taken to hosp;pt final dx was encephalomyeloneuritis;
On 12/3/21 around 10:30am a mother asked for assistance for her 9 year old boy that was developing a rash on his chest while in observation after receiving his second vaccination. The mother stated her child did not have any reaction with the first covid vaccine. The child did not have any shortness of breath, airway swelling or chest tightness. The only complaint was the rash that started on the chest and spread to his left shoulder. The child did not have any pertinent medical history.   The child was assisted to a more private area where a set of vital signs were taken and he was exposed. The child was given 5ml of oral Benadryl with significant improvement. Before the child left, the rash was gone with minimal itchiness.     Medication administered: Oral Benadryl 5ml
pt recvd pertussis vax; created a persistant cry up to 2 hrs;
Pain, swelling, redness, patient received staph infection. Patient is now taking Keflex, doxycycline and laratabs.
PATIENT STARTED DEVELOPING RED SPOTS ALL OVER BOTH ARMS APPROX 15 MINS AFTER VACCINE WAS ADMINISTERED. PATIENT WAS GIVEN BENADRYL 25 MG(DECLINED 50 MG DOSE)AT 12:45 PM ALONG WITH WATER AND ICE PACK. AFTER 15 MINS PT REPORTED BURNING SENSATION GOING DOWN BOTH HER ARMS, PAINFUL SWALLOWING BUT NOT UNABLE TO SWALLOW AND TINGLING IN HER LIPS BUT NO SWELLING. PATIENT WAS ASKED IF WE CAN CALL 911 SO SHE CAN GET EMERGENCY CARE, PATIENT DECLINED AND WANTED HER DAUGHTER TO DRIVE HER TO THE HOSPITAL. PATIENT WAS CARRYING EPIPEN AND KNOW HOWS TO USE.
I21.4 ACUTE NON ST ELEVATION MI 3/24/2023 ACUTE NON ST ELEVATION MI CAD WO ANGINA DUE TO LIPID RICH PLAQUE
Itching. Breathing issues coughing. Sneezing. Extreme allergies. Headache sinus drainage running nose.
Patient fainted in the store after leaving the waiting area near pharmacy. Store called 911 and EMT treated patient. Her vitals were checked and found to be normal and they drove patient home
24hrs p/vax devel rash both arms, chest, neck, stomach-no swelling rash is itchy;rx DPH
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 54-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 15Apr2021 at 15:00 as dose 1, single (Lot number: ER8732) at the age of 53 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: FLUID RETENTION (non-serious), outcome "unknown", described as "Fluid removed each symptom Started about 1 month after each dose". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of fluid retention. Additional Information: The patient has no known allergies.Sender's Comments: Linked Report(s) : PFIZER INC-202201058175 same patient, vaccine, different dose and event; PFIZER INC-202201058174 same patient, vaccine, different dose and event; PFIZER INC-202201058176 same patient, vaccine, different dose and event.
10/14/09 - Received FluMist influenza vaccine.Abdominal pain,weakness,loss of appetite, cough started. 10/15/09 - abdominal pain/weakness continued, fever at 100 degrees, moist non productive cough increased 10/16/09 - high fever at 103.8, cough increased, very weak, loss of appetite 10/17/09 - 10/18/09 - coarse cough, rapid breathing at 36 bpm, increased heart rate at up to 130 bpm, abdominal pain with vomiting, fever at 102.7 degrees F, not responding to tylenol given overnight at home. ER visit, Xray confirmed pneumonia, nasal specimen for FA Respiratory Virus/Reflex Flu A PCR test confirmed Influenza A.
Early on 7/7/22 am I woke unable to walk safely, as I lurched from side to side, extreme disequlibrium. I also had not awakened in the  night to pee or drink any water which I usually do and though I peed as soon as I got up there was very little urine expressed. That wa when I had to hold on to furniture and doorways and walls to keep from toppling over.  I called a nurse telling them I thought I had vertogo. She took down my sumptoms and age and exisiting conditions and discussed my case with her consulting doctor, who told me to go to the ER>.I had to call an ambulance as my most available neighbor was not available. Ambulance took me, had me hooked up to equpment that took my vitals. My blood glucose was high, 200, but everything else was OK, blood pressure a little high. At the ER did some quick checks with fingers, hands, facial movements, etc. Hooked me up to an ekg, took a blood sample and began hydrating me.  My vitals were fine, I was given another more rigorous set of hand, eye, finger movements to mimin and complete, strength tests and so on. All of these indicated that there was no stroke and the disequilibrium was vertigo. They don't know why, but the disequilibrium was not in my brain but in my ear canal. I wear hearing aids, last year had an intense infection in one ear, but otherwise everything was normal. I am only filling this out because it was just a few days from my fourth shot, the second booster. For the second shot I had mild but pervasive symtpoms that began ten to eleven days after the shot. I figured I might as well log this one in as perhaps this will show up as a common resposne or it will not show up in anyone else's reactions.
Severe pain in multiple joints: Hips, knees, wrist, thumbs. Also shooting pains in palms of hands.
Information has been received from a dentist concerning a 62 year old female patient with fibromyalgia, hypertension, osteoporosis, arthritis, irritable bowel syndrome, right bundle branch block and erythromycin allergy and a history of pneumonia, gall bladder disorder, bronchitis, reflux and benign thyroid tumor in which there was a thyroidectomy who on 11-MAR-2010 was vaccinated with a dose of ZOSTAVAX (Merck). Concomitant therapy included nifedipine, meloxicam, metoclopramide, SYNTHROID, CYMBALTA, MIRALAX, ezetimibe (MSD), TRICOR, DEXILANT ("Capidex") NUVIGIL, BONIVA, multivitamins (unspecified), CALTRATE + Vitamin D and aspirin. On approximately 25-APR-2010 (reported as "last week of April 2010"), the patient had oral lesions and some that were bilateral on the soft palate. The dentist reported that "it was like having a permanent sore throat" and the patient could not swallow anything except pureed foods. The patient was last seen by the dentist on 24-JUN-2010 and the patient still had the same lesions. A biopsy performed by the pathologist (lesions not from soft palate but other areas in the mouth) revealed superficial mucocele, and a biopsy performed by the dentist using direct immunoflourescent study revealed all antibodies non reactive. At the time of the report, the patient had not recovered. The dentist considered that the events to be disabling. Additional information has been requested.
Memory loss; mood swings; disorted vision and thoughts; disorted vision and thoughts; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 26Aug2021 as dose 1, single (Lot number: fc3182) at the age of 39 years for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications.  The following information was reported: AMNESIA (non-serious), outcome "not recovered", described as "Memory loss"; MOOD SWINGS (non-serious), outcome "not recovered"; METAMORPHOPSIA (non-serious), THINKING ABNORMAL (non-serious), outcome "not recovered" and all described as "disorted vision and thoughts". The events "memory loss", "mood swings" and "disorted vision and thoughts" required physician office visit. Therapeutic measures were taken as a result of metamorphopsia.  Patient did not develop Covid prior to vaccination. Covid was not tested post vaccination.
backache began 5/10/2021 at 6:30pm and lasted 24 hours fever of 102 degrees / pyrexia began 5/10/2021 at 7:30pm and lasted 24 hours oscillopsia occurred on 5/17/2021 at 4pm and lasted 5 minutes
This spontaneous report as received from a medical assistant refers to a 14 year old patient. On 21-NOV-2015 the patient received the first dose of GARDASIL 9 (dose, route, lot # and expiration date were unknown) for prophylaxis. On 26-JUL-2017, the patient returned to the clinic for the second dose of GARDASIL 9 (inappropriate schedule of drug administration). No adverse effect was reported.
Red rash across chest; The left side of neck hurt and it still does 6 days later; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on an unknown date in Apr2021 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unspecified birth control and phentermine, both from unknown dates for unknown indications and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021, the patient went back to work after shot and experienced a red rash across chest. Later that evening, the patient experienced left side of her neck hurt and it still persisted 6 days later. This concerned the patient as it didn't hurt prior to the shot. The patient's neck had always been fine until the time of report. The patient stated that the rash went away. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event red rash across chest was recovered on an unknown date in Apr2021. While that of the event neck hurt was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Fatigue & High Fever for 48 hours. Day-1: 103deg Day-2: 102deg
Vaccine Reaction: Nauseated, Syncope and sweating   Description of Event: Pt found in observation chair, sweaty and nauseous and had about a 1 minute syncopal episode observed by OBS RN. Pt slow to arouse post syncope. Able to ambulate 2 steps and placed on gurney. Taken outside of the building by exit doors. Pt sleepy and sweaty, placed on vital sign machine. Dr. and multiple RN's with patient. Pt remained slightly nauseous at 1033. Pt had eaten breakfast and denies any medical history or meds. 1035 attempt sips of water, 1038 we called his girlfriend to come be with him and drive him home. Pt felt like he couldn't get enough air at 1038, we removed both of his masks at this time. Pt was sweaty again, but oxygen sats were 100%. 1056 GF arrived. 1106 we attempt to sit up patient slightly and he gets lightheaded and request to lie flat again. Sips of water causes nausea. Dr. remains at BS with patient. Pt began feeling a whole body tingle, encouraged to take nice slow easy breaths. 1111 took a bite of granola bar.  1143 tried sitting up again, gets lightheaded and laid back down. 1154 Dr. back at bedside. 1200 Pt cold bath blanket put on patient. Pt had periods of being slightly pale during observation period and dry mucuous membranes.Pt refusing to try water or granola bar at this time. 1205 pt began to vomit stomach contents.1212 Dr. back at BS to evaluate patient. Pt feels slightly better, taking sips of water. 1220 pt has been able to lay with head up on his left side now for 20 mins. Dr. offered to send patient to ER to get IVF and be checked out, pt began to perk up and wanted to go home. Orthostatic VS done and remain stable. GF is agreeable to take patient home and monitor him, she is not going in to work today. Pt taken to car via wheelchair, assisted in car, able to walk a few steps. Advised by Dr. to eat a salty meal and drink plenty of fluids and rest. Go to ER if symptoms worsen. Also advised by this RN to follow up with his PCP and let them know of his syncope with vaccine. Pt also advised if he dose get the second vaccine to let them know up front he faints and will be given vaccine in reclining chair.
Patient stated that she woke up in the middle of the night that she received the vaccine sore and in severe pain everywhere. It was hard for her to sleep with the symptoms, but it resolved by the morning.
pt recv vax JAN97 & approx 26JAN98 pt devel a varicella rash;
Mother contacted office that child was turning blue and not breathing.  Advised to call 911 and child admitted to hospital with O2 sats in the 70's and remains there with multiple physician consults.
Breakthrough COVID19 infection,.  Patient's vaccination dates were 2/4/21 and 2/24/21.  Developed symptomatic COVID19 infection on 7/16/21.
Headache at around 10:00 PM, followed by body shaking, teeth chattering , chills and vomiting approximately 3-4 hours later
MMR and PREVNAR given, child within seconds had a seizure lasting no more than 15 seconds. He had another seizure several hours later and with third several days later.
Patient developed burning tongue and metallic taste in mouth within 24-48 hours of the immunization
1445 Injection given 1457 c/o right arm tingling from shoulder to fingertips and right sided facial tingling 1505 Benadryl 50mg liquid po given 1510 Resp 20, Pulse61, SAO2 98% on RA. Denies any difficulty breathing.  1520 Rt arm tingling improved and facial tinging subsided 1530 All symptoms subsided. Pulse 66, SAO2 98% on RA, Resp 20. Denies any difficulty breathing. Discharged home. Informed to follow up with PCP. Verbalized understanding.
Headache Narrative:  Side Effects: Dose 1: Days 1 and 2: sore, stiff arm and HA Dose 2: Days 1 - 3: swelling, stiffness, sore (localized). Generalized: Day 1: HA, fever. Day 2 fever, chills, body aches, HA, fatigue, joint pain in jaw. Day 3: fatigue.
Pt experienced chest pain and heaviness, pain with swallowing and shortness of breath an hour after vaccine administered.
Patient said both arms were red and swollen the size of a baseball. Both arms were sore. The Left arm was the worst and of the longest duration. It also had a hard lump. She had fever for a day. She called her doctor who advised BENADRYL. She took BENADRYL until the symptoms went away. She showed it to a doctor when she went along to her daughter's doctor visit, but was not treated.
8/17/05 Dtap/ IPV given right arm. Call from parent, swollen right arm, hot to touch, discussed instruction, for Tylenol and ice. Checked on Friday, better, gone by Saturday via mother.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 73-year-old female patient who received SHINGRIX (batch number 3Z4KL, expiry date 30th January 2019). The patient's past medical history included diabetes. On 6th February 2018, the patient received SHINGRIX (intramuscular). On 6th February 2018, 20 min after receiving SHINGRIX, the patient experienced pain in arm, mass, hyperglycemia, sleepiness and tiredness. On 7th February 2018, the patient experienced throat swelling and foggy feeling in head. On an unknown date, the outcome of the pain in arm, mass, hyperglycemia, sleepiness, throat swelling, foggy feeling in head and tiredness were unchanged. The reporter considered the pain in arm, mass, hyperglycemia, sleepiness, throat swelling, foggy feeling in head and tiredness to be almost certainly related to SHINGRIX. Additional details were provided as follows: The reporter reported herself that she experienced arm pain described as fiery and with a lump on it. The patient reported that her throat felt swollen up. On 6th February 2018, less than a day, the patient experienced mass, hyperglycemia, sleepiness and tiredness. On 7th February 2018, 1 day after vaccination, the patient experienced throat swelling and foggy feeling in head. The patient reported brain fog, described as not being with it. The patient reported that she was sleeping too long and tired. The patient reported that she felt hyperglycemic, but did not test her glucose levels.
Moderna COVID-19 Vaccine  Chill and shaking after sunset for 2 nights and normal from 3rd day
the injection site is swollen; the injection site is / painful; area is red from the injection site down to the elbow/the injection site is / red; This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 75-year-old female patient who received Herpes zoster (Shingrix) (batch number HD3K2, expiry date 7th May 2022) for prophylaxis.   On 9th December 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 weeks after receiving Shingrix, the patient experienced injection site swelling, injection site pain and erythema of extremities. On an unknown date, the outcome of the injection site swelling, injection site pain and erythema of extremities were unknown.   It was unknown if the reporter considered the injection site swelling, injection site pain and erythema of extremities to be related to Shingrix.  Additional details were provided as follows: The patient was vaccinated with 2nd dose of Shingrix in left arm. The patient experienced injection site swelling, redeness and pain. The pharmacist reported that the area was red from the injection site down to the elbow. The reporter gave consent to follow up.
This spontaneous report as received from a medical assistant refers to a female patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 05-AUG-2016, the patient was vaccinated with her second dose of improperly stored dose of VARIVAX lot # L046884, expiration date 23-NOV-2017, 0.5 ml, subcutaneous. There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 23.9 degrees Fahrenheit for 1 hour 25 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reported received from the same reporter. Additional information has been requested.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 20-AUG-2015, the patient was inoculated with ZOSTAVAX by the physician as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster or shingles. On or about 19-JAN-2016, the patient was treated by the physician for a persistent and severe vesicular rash, which was diagnosed as shingles. The patient was prescribed VALTREX for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Patient received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of UNDERDOSE (Patient received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On an unknown date, the patient experienced UNDERDOSE (Patient received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (Patient received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (Patient received 0.25 mL of Moderna Covid-19 Vaccine, Bivalent).    No concomitant medications were reported. It was unknown whether patient received any other vaccines in the 4 weeks prior to COVID-19.  Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 27-Dec-2022: Live Significant Follow-up appended: Patient details (Age group) was added.
Injection site pain and swelling, Lost ROM left upper arm and shoulder by 1/28/2021 am. Arm weak and stiff. Narrative: 1/28/2021 AM lost ROM of left upper arm and shoulder. Minimal ROM due to weakness and stiffness. No etiology determined for loss of ROM at facility. 2/1/2021 Returned to duty. Motion in her arm is back to normal. Still tender and has a little pain.
Cried for 4 hrs after immunization-refuse feeding at the time less active next day.